Molecular dynamics simulations of asymmetric heterodimers of HER1/HER2 complexes

被引:0
|
作者
Chonticha Suwattanasophon
Napat Songtawee
Peter Wolschann
Kiattawee Choowongkomon
机构
[1] Kasertsart University,Department of Biochemistry, Faculty of Science
[2] Kasetsart University,Center for Advanced Studies in Tropical Natural Resources, National Research University
[3] Mahidol University,Kasetsart University
[4] University of Vienna,Department of Clinical Chemistry, Faculty of Medical Technology
[5] University of Vienna,Institute for Theoretical Chemistry
来源
关键词
HER family; Molecular dynamics simulation; Heterodimer; HER1; ErbB2;
D O I
暂无
中图分类号
学科分类号
摘要
The family of human epidermal growth factor receptors (HER) is involved in tumor cell growth. Homodimerization and heterodimerization of the HER family are important for activation of these receptors. The structures of homodimer conformation are well characterized, while the structures of heterodimer conformations, especially between HER1 and HER2, are not completely understood. In this study, two models of possible asymmetric HER1/HER2 kinase domains were built. Molecular dynamics simulations and molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) methods were applied to examine the possibility of these two-heterodimer interactions. From our results, it could be concluded that the HER2 kinase domain prefers to serve as the receiver rather than the activator. Key binding residues of this dimer complex at N lobe of HER2 is ALA683 and at C lobe of HER1 are GLU914, GLU917, and ASP930. This study will be useful in allowing us to predict and be able to control activity of this enzyme in disease in the future.
引用
收藏
相关论文
共 50 条
  • [1] Molecular dynamics simulations of asymmetric heterodimers of HER1/HER2 complexes
    Suwattanasophon, Chonticha
    Songtawee, Napat
    Wolschann, Peter
    Choowongkomon, Kiattawee
    JOURNAL OF MOLECULAR MODELING, 2018, 24 (01)
  • [2] HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
    Freeman, MR
    CANCER CELL, 2004, 6 (05) : 427 - 428
  • [3] TRANSMODULATION OF HER2 LEVELS BY HER1 ACTIVATION
    WORTHYLAKE, B
    WILEY, HS
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1374 - 1374
  • [4] Development of proximity-based immunoassays for activated HER1, HER2, and HER1-HER2 heterodimers in formalin-fixed, paraffin-embedded (FPPE) cells
    Defazio-Eli, L.
    Wallweber, J.
    Frankson, K.
    Dao-Pick, T.
    Dang, T.
    Dua, R.
    Goodman, L.
    Parry, G.
    Winslow, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 30 - 30
  • [5] A novel dual inhibitor of HER1 and HER2 protein tyrosine kinases
    Mastalerz, H
    Dextraze, P
    Gavai, A
    Johnson, W
    Lee, F
    Oppenheimer, S
    Ruediger, E
    Tarrant, J
    Vite, G
    Vyas, D
    Wong, TW
    Zhang, GF
    Zhang, HJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2717 - U2717
  • [6] Ultrasensitive assay of HER1, HER2, and heregulin- α in whole blood
    Staden, Raluca-Ioana Stefan-van
    Musat, Oana-Raluca
    Gheorghe, Damaris-Cristina
    Ilie-Mihai, Ruxandra-Maria
    Negut, Catalina Cioates
    Sfirloaga, Paula
    TALANTA OPEN, 2022, 6
  • [7] Expression of Her1 and Her2 in MSI positive and negative colonic adenocarcinoma
    Hsieh, E
    Plotkin, A
    Khalifa, M
    Khalil, M
    Hanna, WM
    LABORATORY INVESTIGATION, 2006, 86 : 109A - 109A
  • [8] Expression of Her1 and Her2 in MSI positive and negative colonic adenocarcinoma
    Hsieh, E
    Plotkin, A
    Khalifa, M
    Khalil, M
    Hanna, WM
    MODERN PATHOLOGY, 2006, 19 : 109A - 109A
  • [9] Exploration of an aminothiazole dual HER2/HER1 kinase inhibitor.
    Mastalerz, H
    Chang, M
    Johnson, W
    Kadow, J
    Langley, D
    Vite, G
    Vyas, D
    Wong, TW
    Zhang, GF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U12 - U12
  • [10] New dual inhibitors of HER1 and HER2 protein tyrosine kinases.
    Vite, GD
    Mastalerz, H
    Fink, BE
    Gavai, AV
    Hunt, JT
    Tokarski, JS
    Vyas, DM
    Wong, TW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U3 - U3